Safety and efficacy of Cesium-131 brachytherapy for brain tumors-Reference-Cited by-同舟云学术

Safety and efficacy of Cesium-131 brachytherapy for brain tumors

Published:2023-05-30 Issue:2 Volume:163 Page:355-365
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Bander Evan D.,Kelly Alexander,Ma Xiaoyue,Christos Paul J.,Wernicke A. Gabriella,Stieg Philip E.,Trichter Samuel,Knisely Jonathan P.S.,Ramakrishna Rohan,Schwartz Theodore H.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-023-04352-0.pdf

Reference55 articles.

1. Patchell RA, Tibbs PA, Regine WF et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280(17). https://doi.org/10.1001/jama.280.17.1485

2. Mahajan A, Ahmed S, McAleer MF et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8). https://doi.org/10.1016/S1470-2045(17)30414-X

3. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352(10). https://doi.org/10.1056/nejmoa043330

4. Bander ED, Yuan M, Reiner AS et al (2021) Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control. Neuro-Oncology Pract 8(3). https://doi.org/10.1093/nop/npab005

5. Roth O’Brien DA, Poppas P, Kaye SM et al (2021) Timing of adjuvant fractionated stereotactic Radiosurgery affects local control of Resected Brain Metastases. Pract Radiat Oncol 11(3). https://doi.org/10.1016/j.prro.2021.01.011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapy in Brain Metastasis Treatment: A Scoping Review of Advances in Techniques and Clinical Outcomes;Cancers;2024-07-31

2. Impact of adjuvant interstitial brachytherapy on lengths of stay, discharge disposition, and 30-/90-day readmission for malignant brain tumor patients: a National Readmission Database analysis;2024-04-24

3. Analysis of risk factors affecting wound healing and wound infection after meningioma resection;International Wound Journal;2024-04

4. The role of GammaTile in the treatment of brain tumors: a technical and clinical overview;Journal of Neuro-Oncology;2024-01

5. First application of GammaTile cesium-131 brachytherapy with maximal safe resection of a glioma in a patient with limited scleroderma;Journal of Contemporary Brachytherapy;2023